Cell Reports (Aug 2023)

Transplantation elicits a clonally diverse CD8+ T cell response that is comprised of potent CD43+ effectors

  • Gregory S. Cohen,
  • Melissa A. Kallarakal,
  • Sahana Jayaraman,
  • Francis I. Ibukun,
  • Katherine P. Tong,
  • Linda D. Orzolek,
  • H. Benjamin Larman,
  • Scott M. Krummey

Journal volume & issue
Vol. 42, no. 8
p. 112993

Abstract

Read online

Summary: CD8+ T cells mediate acute rejection of allografts, which threatens the long-term survival of transplanted organs. Using MHC class I tetramers, we find that allogeneic CD8+ T cells are present at an elevated naive precursor frequency relative to other epitopes, only modestly increase in number after grafting, and maintain high T cell receptor diversity throughout the immune response. While antigen-specific effector CD8+ T cells poorly express the canonical effector marker KLRG-1, expression of the activated glycoform of CD43 defines potent effectors after transplantation. Activated CD43+ effector T cells maintain high expression of the coreceptor induced T cell costimulator (ICOS) in the presence of CTLA-4 immunoglobulin (Ig), and dual CTLA-4 Ig/anti-ICOS treatment prolongs graft survival. These data demonstrate that graft-specific CD8+ T cells have a distinct response profile relative to anti-pathogen CD8+ T cells and that CD43 and ICOS are critical surface receptors that define potent effector CD8+ T cell populations that form after transplantation.

Keywords